To delve deeper into the mechanisms by which testosterone may counteract the effects of TACR3 deficiency, we administered either osanetant (100 nM), testosterone (10 nM), or a combination of both drugs to neurons. The gene discussed is TACR3; the disease is hyperinsulinemic hypoglycemia, familial, 4.